Michal Bystrzejewski Selected Research

Melanoma (Melanoma, Malignant)

1/2024	Monoclonal antibody-navigated carbon-encapsulated iron nanoparticles used for MRI-based tracking integrin receptors in murine melanoma.
1/2023	Graphene-encapsulated iron nanoparticles as a non-viral vector for gene delivery into melanoma cells.
1/2013	Cytotoxicity evaluation of carbon-encapsulated iron nanoparticles in melanoma cells and dermal fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michal Bystrzejewski Research Topics

Disease

3	Melanoma (Melanoma, Malignant) 01/2024 - 01/2013
2	Neoplasms (Cancer) 01/2023 - 01/2013
2	AIDS-Related Complex (ARC) 08/2016 - 04/2014
1	Glioma (Gliomas) 05/2014
1	Lewis Lung Carcinoma 04/2014

Drug/Important Bio-Agent (IBA)

6	CarbonIBA 01/2024 - 01/2013
5	IronIBA 01/2024 - 01/2013
3	calcein AMIBA 05/2014 - 01/2013
2	Annexin A5IBA 05/2014 - 04/2014
2	Propidium (Propidium Iodide)IBA 04/2014 - 01/2013
1	IntegrinsIBA 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	Contrast MediaIBA 01/2024
1	Nucleic AcidsIBA 01/2023
1	PolyethyleneimineIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	GraphiteIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	BromidesIBA 04/2014
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2014
1	FITC-annexin A5IBA 01/2013